{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:54Z","timestamp":1789140474077,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10620-018-4948-0","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T20:39:12Z","timestamp":1519159152000},"page":"974-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers"],"prefix":"10.1007","volume":"63","author":[{"given":"Ai","family":"Hirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-0977","authenticated-orcid":false,"given":"Toshihisa","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tokioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"4948_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/gut.48.2.225","volume":"48","author":"H Ono","year":"2001","unstructured":"Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225\u2013229.","journal-title":"Gut"},{"key":"4948_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3164\/jcbn.11-23","volume":"49","author":"N Takeuchi","year":"2011","unstructured":"Takeuchi N, Umegaki E, Takeuchi T, et al. Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H2-receptor antagonist and proton pump inhibitor administration. J Clin Biochem Nutr. 2011;49:216\u2013221.","journal-title":"J Clin Biochem Nutr"},{"key":"4948_CR3","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1572-0241.2007.01197.x","volume":"102","author":"N Uedo","year":"2007","unstructured":"Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol. 2007;102:1610\u20131616.","journal-title":"Am J Gastroenterol"},{"key":"4948_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-2007-995530","volume":"40","author":"K Takizawa","year":"2008","unstructured":"Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-an analysis of risk factors. Endoscopy. 2008;40:179\u2013183.","journal-title":"Endoscopy"},{"key":"4948_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.bcp.2011.02.009","volume":"81","author":"J Matsukawa","year":"2011","unstructured":"Matsukawa J, Hori Y, Nishida H, et al. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. Biochem Pharmacol. 2011;81:1145\u20131151.","journal-title":"Biochem Pharmacol"},{"key":"4948_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/jpet.111.179556","volume":"337","author":"Y Hori","year":"2011","unstructured":"Hori Y, Matsukawa J, Takeuchi T, et al. A study comparing the antisecretory effect of Tak-438, a novel potassium-competitive acid blocker, with lansoprazole in animals. J Pharmcol Exp Ther. 2011;337:797\u2013804.","journal-title":"J Pharmcol Exp Ther"},{"key":"4948_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/apt.13331","volume":"42","author":"K Ashida","year":"2015","unstructured":"Ashida K, Sakurai Y, Nishimura A, et al. Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther. 2015;42:685\u2013695.","journal-title":"Aliment Pharmacol Ther"},{"key":"4948_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ajg.2016.182","volume":"111","author":"S Suzuki","year":"2016","unstructured":"Suzuki S, Gotoda T, Kusano C, Iwatsuka K, et al. The efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker compared with a 7-day ppi-based low-dose clarithromycin triple therapy. Am J Gastroenterol. 2016;111:949\u2013956.","journal-title":"Am J Gastroenterol"},{"key":"4948_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2169\/internalmedicine.56.7833","volume":"56","author":"S Sue","year":"2017","unstructured":"Sue S, Kuwashima H, Iwata Y, et al. The superiority of vonoprazan-based first-line triple therapy with clarithromycin: a prospective multi-center cohort study on helicobacter pylori eradication. Intern Med. 2017;56:1277\u20131285.","journal-title":"Intern Med"},{"key":"4948_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000478255","volume":"96","author":"H Yamashita","year":"2017","unstructured":"Yamashita H, Kanamori A, Kano C, et al. The effects of switching to vonoprazan, a novel potassium-competitive acid blocker, on gastric acidity and reflux patterns in patients with erosive esophagitis refractory to proton pump inhibitors. Digestion. 2017;96:52\u201359.","journal-title":"Digestion"},{"key":"4948_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/den.12705","volume":"29","author":"D Maruoka","year":"2017","unstructured":"Maruoka D, Arai M, Kasamatsu S, et al. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: a propensity score-matching analysis. Dig Endosc. 2017;29:57\u201364.","journal-title":"Dig Endosc"},{"key":"4948_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4253\/wjge.v8.i19.716","volume":"8","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Sato Y, Kohisa J, et al. Vonoprazan 20\u00a0mg vs lansoprazole 30\u00a0mg for endoscopic submucosal dissection-induced gastric ulcers. World J Gastrointest Endosc. 2016;8:716\u2013722.","journal-title":"World J Gastrointest Endosc"},{"key":"4948_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/den.12857","volume":"29","author":"I Tsuchiya","year":"2017","unstructured":"Tsuchiya I, Kato Y, Tanida E, et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial. Dig Endosc. 2017;29:576\u2013583.","journal-title":"Dig Endosc"},{"key":"4948_CR14","unstructured":"Japanese Gastric Cancer Society. evidence-based clinical practice guidelines for diagnosis and treatment of carcinoma of stomach. Cited May 2014. URL: \n                    http:\/\/www.jgca.jp\/guideline\/fourth\/index.html\n                    \n                   (in Japanese)."},{"key":"4948_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1055\/s-2003-41516","volume":"35","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto H, Kawata H, Sunada K, et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy. 2003;35:690\u2013694.","journal-title":"Endoscopy"},{"key":"4948_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1443-1661.2005.00459.x","volume":"17","author":"I Oda","year":"2005","unstructured":"Oda I, Gotoda T, Hamanaka H, et al. Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc. 2005;17:54\u201358.","journal-title":"Dig Endosc"},{"key":"4948_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/apt.13121","volume":"41","author":"H Jenkins","year":"2015","unstructured":"Jenkins H, Sakurai Y, Nishimura A, et al. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther. 2015;41:636\u2013648.","journal-title":"Aliment Pharmacol Ther"},{"key":"4948_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitor effects of vonoprazan 20\u00a0mg compared with esomeprazole 20\u00a0mg or lansoprazole 10\u00a0mg in healthy adult male subjects-a randomized open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u2013730.","journal-title":"Aliment Pharmacol Ther"},{"key":"4948_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/apt.13747","volume":"44","author":"T Kagawa","year":"2016","unstructured":"Kagawa T, Iwamuro M, Ishikawa S, et al. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers. Aliment Pharmacol Ther. 2016;44:583\u2013591.","journal-title":"Aliment Pharmacol Ther"},{"key":"4948_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13876","volume":"45","author":"H Miwa","year":"2017","unstructured":"Miwa H, Uedo N, Watari J, et al. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers\u2014results from two phase 3, non-inferiority randomised controlled trials. Aliment Pharmacol Ther. 2017;45:240\u2013252.","journal-title":"Aliment Pharmacol Ther"},{"key":"4948_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1440-1746.2012.07144.x","volume":"27","author":"T Tomita","year":"2012","unstructured":"Tomita T, Kim Y, Yamasaki T, et al. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2012;27:1441\u20131446.","journal-title":"J Gastroenterol Hepatol"},{"key":"4948_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/den.12518","volume":"28","author":"O Hiroyuki","year":"2016","unstructured":"Hiroyuki O, Kenshi Y, Mitsuhiro F, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28:3\u201315.","journal-title":"Dig Endosc"},{"key":"4948_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-230X-13-136","volume":"13","author":"T Takeuchi","year":"2013","unstructured":"Takeuchi T, Ota K, Harada S, et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol. 2013;13:136.","journal-title":"BMC Gastroenterol"},{"key":"4948_CR24","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1007\/s00464-015-4123-z","volume":"29","author":"JH Lim","year":"2015","unstructured":"Lim JH, Kim SG, Choi J, et al. Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection. Surg Endosc. 2015;29:3666\u20133673.","journal-title":"Surg Endosc"},{"key":"4948_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/gut.28.2.210","volume":"28","author":"G Battaglia","year":"1987","unstructured":"Battaglia G, Di Mario F, Piccoli A, et al. Clinical markers of slow healing and relapsing gastric ulcer. Gut. 1987;28:210\u2013215.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-4948-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-4948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-4948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T20:25:40Z","timestamp":1550694340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-4948-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4948"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-4948-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}